Each day more resources are available to medical treatments through scientific and technological developments. Those, however, come with an exponential increase in costs and in the risks of inadequate or even unnecessary procedures.
Evidencias elaborates technical and scientific reports to guide the standardization of materials, medicaments and procedures and applies algorithms to computer systems to reduce the waste of resources on the course of treatments. Auditing processes on high cost procedures, chemotherapy and radiotherapy treatments are offered through the internet, hindering the use of treatments considered experimental or without adequate scientific support. The result is up to 25% reduction* in expenses, with high return over investment.
* varies according to the field of application
Auditing for pre-approval of high cost materials and medicaments
We act as consultants on the pre-approval requisitions for high cost drugs, materials and procedures. Using criteria that are based on the best evidence, the approval of drugs/procedures that are still considered experimental or lacking in evidence is denied, avoiding wasted and the continuance of harmful or unnecessary practices
Billing review
Specially in chemotherapy, the proper use of drug vials and dose adjustments can optimize the costs and reduce waste.
Health Technology Assessment (HTA)
A rigorously scientific evaluation on the effectiveness of drugs, materials and medical procedures generating the technical-scientific guideline for immediate use of administrative and auditing personnel. These documents are constantly being updated and are available through:
Clinical Guidelines
We develop algorithms to establish a homogenous flow of standard medical procedures, avoiding waste of resources and time, according with the best available evidence.
Algorithm Development
We develop algorithms to support the authorization of drugs, materials and procedures on computerized systems in order to speed the process and avoid misuse of resources.
Pharmacoeconomic Studies
We develop economic studies on drugs, materials and procedures in order to optimize the budget and reduce the waste of valuable resources.